Re-run eP2P Should Olumiant® be the JAKi of choice in rheumatoid arthritis? A review of the evidence

Re-run  eP2P Should Olumiant®  be the JAKi of choice in  rheumatoid arthritis? A review of the evidence English

This Activity for

  • Resident / Fellow
  • Physician

What I will learn?

- To review the latest Olumiant real world evidence and demonstrate the
consistency of results between this and the clinical evidence.
- To discuss why Olumiant should be used earlier in the treatment pathway
and is the perfect molecule to implement a treat to target approach.
- To agree that Olumiant should be a good contender for JAKI of choice.

Additional items to the activity

Optional Details Type Fee
Re-run eP2P Should Olumiant® be the JAKi of choice in rheumatoid arthritis? A review of the evidence Certificate

Certificate

Certificate Free
VAT 15% Included

About Organizer

Contact the organizer and they will be glad to help!

Virtual Medical Academy

was 0 SAR

Free
0%coupon Discount
  • calendar 21 Feb 2024
  • clock 09:30 pm - 10:30 pm - Saudi Arabia (+03:00)
  • quality Certificate Available
  • adjust no access Materiel
  • Registration Policy Full Course
  • Completion Role You must attend all the Sessions
  • Refund Policy No Refund
Free